Public health experts warn that a major communication failure could worsen mistrust of vaccines, a problem brought to light ...

The investigators found that one laboratory value—elevated erythrocyte sedimentation rate (ESR)—was also tied with longer ...

Melanoma affects nearly 100,000 Americans annually and caused close to 8,000 deaths in 2023. Early detection significantly ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

Independence Blue Cross's Medicare Advantage plans received 4 out of 5 stars from CMS for 2026, excelling in customer service and preventive care. The CMS Star Rating Program evaluates plans on up to ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...